Factors affecting periprocedural morbidity and mortality and long-term patient survival after arterial embolization of hepatic neuroendocrine metastases

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 1, 2014, Pages 22-30

  Sofocleous, Constantinos T ^a   Petre, Elena N ^a   Gonen, Mithat ^a   Reidy Lagunes, Diane ^a   Ip, Ivan K ^a   Alago, William ^a   Covey, Anne M ^a   Erinjeri, Joseph P ^a   Brody, Lynn A ^a   Maybody, Majid ^a   Thornton, Raymond H ^a   Solomon, Stephen B ^a   Getrajdman, George I ^a   Brown, Karen T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN;

ACUTE ABDOMEN; ADULT; AGED; AIRWAY PRESSURE; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTERY DISSECTION; ARTERY RECONSTRUCTION; ARTICLE; ARTIFICIAL EMBOLISM; ASPIRATION PNEUMONIA; CANCER OF UNKNOWN PRIMARY SITE; CARCINOID; CARDIOPULMONARY ARREST; CHOLECYSTITIS; CHOLECYSTOSTOMY; CHRONIC PATIENT; ELECTROLYTE DISTURBANCE; FEMALE; FEMORAL ARTERY; GASTRINOMA; GLUCAGONOMA; HEPATIC ARTERY; HEPATIC ARTERY EMBOLIZATION; HUMAN; HYPOGLYCEMIA; INSULINOMA; KIDNEY FAILURE; LIVER ABSCESS; LIVER METASTASIS; LIVER SURGERY; LONG TERM SURVIVAL; LUNG EDEMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PANCREAS ISLET CELL TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEIZURE; SEPSIS; SOMATOSTATINOMA; TUMOR RECURRENCE; VERY ELDERLY; VIPOMA; ADVERSE EFFECTS; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MULTIVARIATE ANALYSIS; NEUROENDOCRINE TUMORS; RISK FACTOR; SECONDARY; SEX DIFFERENCE; STATISTICAL MODEL; SURVIVOR; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROENDOCRINE TUMORS; NEW YORK CITY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84896296640     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.09.013     Document Type: Article

References (44)

1. C.G. Moertel, C.M. Johnson, and M.A. McKusick et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas Ann Intern Med 120 1994 302 309
2. D.C. Metz, and R.T. Jensen Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors Gastroenterology 135 2008 1469 1492
3. S. Gupta, M.M. Johnson, and R. Murthy et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival Cancer 104 2005 1590 1602
4. A. Roche, B.V. Girish, and T. de Baere et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors Eur Radiol 13 2003 136 140
5. P. Ruszniewski, P. Rougier, and A. Roche et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients Cancer 71 1993 2624 2630
6. E. Therasse, F. Breittmayer, and A. Roche et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis Radiology 189 1993 541 547
7. K. Memon, R.J. Lewandowski, and M.F. Mulcahy et al. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes Int J Radiat Onco Biol Phys 83 2012 887 894
8. R.S. Chamberlain, D. Canes, and K.T. Brown et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190 2000 432 445
9. C. Sward, V. Johanson, and E. Nieveen van Dijkum et al. Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome Br J Surg 96 2009 517 521
10. K.T. Brown, B.Y. Koh, and L.A. Brody et al. Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms J Vasc Interv Radiol 10 1999 397 403
11. D.C. Madoff, S. Gupta, K. Ahrar, R. Murthy, and J.C. Yao Update on the management of neuroendocrine hepatic metastases J Vasc Interv Radiol 17 2006 1235 1249
12. J.A. Ajani, C.H. Carrasco, C. Charnsangavej, N.A. Samaan, B. Levin, and S. Wallace Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization Ann Intern Med 108 1988 340 344
13. J.G. Drougas, L.B. Anthony, and T.K. Blair et al. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors Am J Surg 175 1998 408 412
14. B.K. Eriksson, E.G. Larsson, B.M. Skogseid, A.M. Lofberg, L.E. Lorelius, and K.E. Oberg Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors Cancer 83 1998 2293 2301
15. H. Hajarizadeh, K. Ivancev, C.R. Mueller, W.S. Fletcher, and E.A. Woltering Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate Am J Surg 163 1992 479 483
16. O. Kress, H.J. Wagner, M. Wied, K.J. Klose, R. Arnold, and H. Alfke Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors - a retrospective single-center analysis Digestion 68 2003 94 101
17. C. Loewe, M. Schindl, M. Cejna, B. Niederle, J. Lammer, and S. Thurnher Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results AJR Am J Roentgenol 180 2003 1379 1384
18. L.J. Perry, K. Stuart, K.R. Stokes, and M.E. Clouse Hepatic arterial chemoembolization for metastatic neuroendocrine tumors Surgery 116 1994 1111 1116
19. W. Kim, T.W. Clark, R.A. Baum, and M.C. Soulen Risk factors for liver abscess formation after hepatic chemoembolization J Vasc Interv Radiol 12 2001 965 968
20. C.H. Dejong, R.W. Parks, E. Currie, J. Piris, D.N. Redhead, and O.J. Garden Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience J R Coll Surg Edinb 47 2002 495 499
21. A. Frilling, J. Li, E. Malamutmann, K.W. Schmid, A. Bockisch, and C.E. Broelsch Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease Br J Surg 96 2009 175 184
22. J.M. Sarmiento, and F.G. Que Hepatic surgery for metastases from neuroendocrine tumors Surg Oncol Clin N Am 12 2003 231 242
23. S. Musunuru, H. Chen, and S. Rajpal et al. Metastatic neuroendocrine hepatic tumors: resection improves survival Arch Surg 141 2006 1000 1004
24. A. Rinke, H.H. Muller, and C. Schade-Brittinger et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group J Clin Oncol 27 2009 4656 4663
25. L.K. Kvols, K.E. Oberg, and T.M. O'Dorisio et al. Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study Endocr Relat Cancer 19 2012 657 666
26. J.C. Yao, M.H. Shah, and T. Ito et al. Everolimus for advanced pancreatic neuroendocrine tumors N Engl J Med 364 2011 514 523
27. E. Raymond, L. Dahan, and J.L. Raoul et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors N Engl J Med 364 2011 501 513
28. K. Oberg, I. Norheim, G. Lundqvist, and L. Wide Cytotoxic treatment in patients with malignant carcinoid tumors. Response to streptozocin - alone or in combination with 5-FU Acta Oncol 26 1987 429 432
29. C.J. Auernhammer, and B. Goke Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin Gut 60 2011 1009 1021
30. A.T. Ruutiainen, M.C. Soulen, and C.M. Tuite et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver J Vasc Interv Radiol 18 2007 847 855
31. F.W. Winkelbauer, B. Niederle, and F. Pietschmann et al. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil AJR Am J Roentgenol 165 1995 323 327
32. B. Guiu, F. Deschamps, and S. Aho et al. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads J Hepatol 56 2012 609 617
33. S.C. Pitt, J. Knuth, and J.M. Keily et al. Hepatic neuroendocrine metastases: chemo- or bland embolization? J Gastrointest Surg 12 2008 1951 1960
34. S. Gupta, J.C. Yao, and K. Ahrar et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience Cancer J 9 2003 261 267
35. T.J. Vogl, T. Gruber, N.N. Naguib, R. Hammerstingl, and N.E. Nour-Eldin Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols AJR Am J Roentgenol 193 2009 941 947
36. C. Lepage, B. Rachet, and M.P. Coleman Survival from malignant digestive endocrine tumors in England and Wales: a population-based study Gastroenterology 132 2007 899 904
37. C. Durante, H. Boukheris, and C. Dromain et al. Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma Endocr Relat Cancer 16 2009 585 597
38. C.C. Solorzano, J.E. Lee, and P.W. Pisters et al. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients Surgery 130 2001 1078 1085
39. F. Yu, D.J. Venzon, and J. Serrano et al. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome J Clin Oncol 17 1999 615 630
40. F. Panzuto, S. Nasoni, and M. Falconi et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization Endocr Relat Cancer 12 2005 1083 1092
41. S. Hur, J.W. Chung, and H.C. Kim et al. Survival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastases J Vasc Interv Radiol 24 2013 947 956
42. R. Dhanasekaran, D.A. Kooby, C.A. Staley, J.S. Kauh, V. Khanna, and H.S. Kim Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study HPB 12 2010 174 180
43. B.L. Dunfee, A. Riaz, and R.J. Lewandowski et al. Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival J Vasc Interv Radiol 21 2010 90 95
44. B. Sangro, L. Carpanese, and R. Cianni et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation Hepatology 54 2011 868 878